Valeant Launches Tender Offer for Allergan

Valeant Pharmaceuticals launched its tender offer for Allergan, taking its roughly $53 billion bid for the Botox maker directly to shareholders.



from WSJ.com: US Business http://ift.tt/1nPjt1Y

via IFTTT